Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIA

Engineering Rhythmic And Responsive Biological Pacemakers Based on The Enhancement Of Cell Intracellular Signaling Targeting Both Ca Cycling And Sarcolemma

  • Read more about Engineering Rhythmic And Responsive Biological Pacemakers Based on The Enhancement Of Cell Intracellular Signaling Targeting Both Ca Cycling And Sarcolemma
US Application 61/180,491
Filed on 2009-05-22

Sperm-derived SPANX-B Is A Clinically Relevant Tumor Antigen That Is Expressed In human Tumors And Readily Recognized By Human CD4+ And CD8+ T Cells

  • Read more about Sperm-derived SPANX-B Is A Clinically Relevant Tumor Antigen That Is Expressed In human Tumors And Readily Recognized By Human CD4+ And CD8+ T Cells
US Application 61/156,435
Filed on 2009-02-27

Design And Generation Of Membrane-targeting And Epitope-tagging Module For Subcloning And Expression Ofmammalian Membrane Proteins

  • Read more about Design And Generation Of Membrane-targeting And Epitope-tagging Module For Subcloning And Expression Ofmammalian Membrane Proteins
US Application 61/142,531
Filed on 2009-01-05

Serum Carboxymethyl-lysine And Circulating Receptor For Advanced Glycation End Products (RAGE) Es Clinical Biomarkers For Adverse Aging-related Outcomes

  • Read more about Serum Carboxymethyl-lysine And Circulating Receptor For Advanced Glycation End Products (RAGE) Es Clinical Biomarkers For Adverse Aging-related Outcomes
US Application 61/133,510
Filed on 2008-06-30

A Bioluminescence Method To Measure Phosphodiesterase Activity

  • Read more about A Bioluminescence Method To Measure Phosphodiesterase Activity
US Application 61/122,056
Filed on 2008-12-12

Individualized Therapy Of Single Gene Disorders By Genetically Modified Adult Stem Cells

  • Read more about Individualized Therapy Of Single Gene Disorders By Genetically Modified Adult Stem Cells
US Application 61/233,537
Filed on 2009-08-13

Milk Fat Globule Epidermal Growth Factor VIII (MFG-E8) And Other Secreted Proteins Increase Markedly With Aging In Rats, Non-human Primates, And Human Arteries And Modulate Arterial Aging And The Response To Arterial Injury

  • Read more about Milk Fat Globule Epidermal Growth Factor VIII (MFG-E8) And Other Secreted Proteins Increase Markedly With Aging In Rats, Non-human Primates, And Human Arteries And Modulate Arterial Aging And The Response To Arterial Injury
US Application 61/154,329
Filed on 2009-02-20

COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES

  • Read more about COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES
US Application 61/045,088
Filed on 2008-04-15

REGULATION OF RELEASE OF GLP-I AND SGLT-l FROM ENTEROENDOCRINE CELLS IN RESPONSE TO AGENTS ACTING ON TASTE SIGNALING MOLECULES In THE Gut

  • Read more about REGULATION OF RELEASE OF GLP-I AND SGLT-l FROM ENTEROENDOCRINE CELLS IN RESPONSE TO AGENTS ACTING ON TASTE SIGNALING MOLECULES In THE Gut
US Application 60/695,463
Filed on 2007-08-20

Method Of Reducing Peptide Aggregration Or Hyperphosphorylation Using A Bisdioxopiperazine

  • Read more about Method Of Reducing Peptide Aggregration Or Hyperphosphorylation Using A Bisdioxopiperazine
US Application 60/811,836
Filed on 2006-06-08

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIA
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health